Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription


1 Am J Pathol
3 BJU Int
1 Cancer
1 Clin Cancer Res
2 Eur Urol
1 Int J Cancer
1 J Cell Physiol
1 J Clin Oncol
3 J Magn Reson Imaging
2 J Nucl Med
6 J Urol
1 Lancet Oncol
1 Nat Rev Urol
1 Oncogene
1 PLoS One
2 Prostate
1 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Pathol

  1. FURLAN T, Kirchmair A, Sampson N, Puhr M, et al
    MYC-mediated ribosomal gene expression sensitizes enzalutamide-resistant prostate cancer cells to EP300/CREBBP inhibitors.
    Am J Pathol. 2021 Mar 8. pii: S0002-9440(21)00084.
    PubMed         Abstract available

    BJU Int

  2. WESSELS F, Schmitt M, Krieghoff-Henning E, Jutzi T, et al
    Deep learning approach to predict lymph node metastasis directly from primary tumor histology in prostate cancer.
    BJU Int. 2021 Mar 11. doi: 10.1111/bju.15386.
    PubMed         Abstract available

  3. ROSENBERG JE, Jung JH, Edgerton Z, Lee H, et al
    Retzius-sparing versus standard robotic assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
    BJU Int. 2021 Mar 9. doi: 10.1111/bju.15385.
    PubMed         Abstract available

  4. DHIANTRAVAN N, Emmett L, Joshua AM, Pattison DA, et al
    UpFrontPSMA: A Randomised Phase 2 Study of Sequential (177) Lu-PSMA617 and Docetaxel versus Docetaxel in Metastatic Hormone-Naive Prostate Cancer.
    BJU Int. 2021 Mar 7. doi: 10.1111/bju.15384.
    PubMed         Abstract available


  5. KWON DH, Chou J, Yip SM, Reimers MA, et al
    Differential Treatment Outcomes in BRCA1/2-, CDK12-, and ATM-Mutated Metastatic Castration-Resistant Prostate Cancer.
    Cancer. 2021 Mar 10. doi: 10.1002/cncr.33487.
    PubMed         Abstract available

    Clin Cancer Res

  6. KAMAT NV, Yu EY, Lee JK
    BiTE-ing into prostate cancer with bispecific T cell engagers.
    Clin Cancer Res. 2021 Mar 11. pii: 1078-0432.CCR-21-0355.
    PubMed         Abstract available

    Eur Urol

  7. GLICKSMAN RM, Metser U, Vines D, Valliant J, et al
    Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.
    Eur Urol. 2021 Mar 5. pii: S0302-2838(21)00151.
    PubMed         Abstract available

  8. LESTINGI JFP, Trinh QD, Coelho RF, Pontes J Jr, et al
    Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymp
    Eur Urol. 2021 Mar 5. pii: S0302-2838(21)00164.

    Int J Cancer

  9. LUEBKE AM, Ricken W, Kluth M, Hube-Magg C, et al
    Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.
    Int J Cancer. 2020;147:575-583.
    PubMed         Abstract available

    J Cell Physiol

  10. ANGEL CZ, Lynch SM, Nesbitt H, McKenna MM, et al
    miR-210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells.
    J Cell Physiol. 2020;235:6194-6203.
    PubMed         Abstract available

    J Clin Oncol

  11. JAN I, Parikh RR
    Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer.
    J Clin Oncol. 2021 Mar 8:JCO2003636. doi: 10.1200/JCO.20.03636.
    PubMed         Abstract available

    J Magn Reson Imaging

  12. CAO R, Zhong X, Afshari S, Felker E, et al
    Performance of Deep Learning and Genitourinary Radiologists in Detection of Prostate Cancer Using 3-T Multiparametric Magnetic Resonance Imaging.
    J Magn Reson Imaging. 2021 Mar 12. doi: 10.1002/jmri.27595.
    PubMed         Abstract available

  13. YAMAMOTO S, Yoshida S, Ishii C, Takahara T, et al
    Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer.
    J Magn Reson Imaging. 2021 Mar 11. doi: 10.1002/jmri.27596.
    PubMed         Abstract available

  14. HAN C, Ma S, Liu X, Liu Y, et al
    Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    J Magn Reson Imaging. 2021 Mar 8. doi: 10.1002/jmri.27565.
    PubMed         Abstract available

    J Nucl Med

  15. DARR C, Harke NN, Radtke JP, Yirga L, et al
    Intraoperative (68)Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study.
    J Nucl Med. 2020;61:1500-1506.
    PubMed         Abstract available

    Prostate-Specific Membrane Antigen: The Target of the Decade, from Biochemical Recurrence to Widespread Adoption.
    J Nucl Med. 2020;61.

    J Urol

  17. MCKAY RR, Xie W, Ye H, Fennessy FM, et al
    Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy Prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.
    J Urol. 2021 Mar 8:101097JU0000000000001702. doi: 10.1097/JU.0000000000001702.
    PubMed         Abstract available

  18. RAJWA P, Pradere B, Mori K, Ploussard G, et al
    Association of Negative Follow-Up Biopsy and Reclassification during Active Surveillance of Prostate Cancer: A Systematic Review and meta-Analysis.
    J Urol. 2021 Mar 8:101097JU0000000000001701. doi: 10.1097/JU.0000000000001701.
    PubMed         Abstract available

  19. MONTORSI F, Gandaglia G, Briganti A
    The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Letter.
    J Urol. 2021 Mar 8:101097JU0000000000001710. doi: 10.1097/JU.0000000000001710.

  20. WENZEL M, Nocera L, Ruvolo CC, Wurnschimmel C, et al
    Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
    J Urol. 2021 Mar 8:101097JU0000000000001695. doi: 10.1097/JU.0000000000001695.
    PubMed         Abstract available

  21. Erratum: Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: Systematic Review and Network Meta-Analysis.
    J Urol. 2021;205:1237.

  22. CARROLL PR, Maggi M
    The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Reply.
    J Urol. 2021 Mar 8:101097JU0000000000001711. doi: 10.1097/JU.0000000000001711.

    Lancet Oncol

  23. AGGARWAL A, Nossiter J, Parry M, Sujenthiran A, et al
    Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit.
    Lancet Oncol. 2021 Mar 4. pii: S1470-2045(20)30558.
    PubMed         Abstract available

    Nat Rev Urol

  24. ZHU Y, Mo M, Wei Y, Wu J, et al
    Epidemiology and genomics of prostate cancer in Asian men.
    Nat Rev Urol. 2021 Mar 10. pii: 10.1038/s41585-021-00442.
    PubMed         Abstract available


  25. PURAYIL HT, Zhang Y, Black JB, Gharaibeh R, et al
    Nuclear betaArrestin1 regulates androgen receptor function in castration resistant prostate cancer.
    Oncogene. 2021 Mar 10. pii: 10.1038/s41388-021-01730.
    PubMed         Abstract available

    PLoS One

  26. JEONG JU, Nam TK, Song JY, Yoon MS, et al
    Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.
    PLoS One. 2021;16:e0248461.
    PubMed         Abstract available


  27. ATEEQ B, Kunju LP, Carskadon SL, Pandey SK, et al
    Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.
    Prostate. 2021 Mar 8. doi: 10.1002/pros.24111.

  28. ZHENG X, Xu H, Gong L, Cao D, et al
    Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation.
    Prostate. 2021 Mar 12. doi: 10.1002/pros.24113.
    PubMed         Abstract available


  29. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021 Mar 9:201852. doi: 10.1148/radiol.2021201852.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.